There were no significant differences in chest CT findings, systemic inflammation or IgM levels in this study, which seems to indicate that the vaccine provides limited protection against mild and common severity of SARS-CoV-2 delta variant infection in patients. The gene discussed is CD40LG; the disease is infection.